Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 730 | 695 | 1,175 | 3,191 |
| Gross Profit | N/A | 730 | 695 | 1,175 | 3,191 |
| Operating Expenses | 73,617 | 64,587 | 63,434 | 57,202 | 55,317 |
| Operating Income | -73,617 | -63,857 | -62,739 | -56,027 | -52,126 |
| Other Income | 6,573 | 7,257 | 8,943 | 8,935 | 10,005 |
| Pre-tax Income | -67,044 | -56,600 | -53,796 | -47,092 | -42,121 |
| Net Income Continuous | -67,044 | -56,600 | -53,796 | -47,092 | -42,121 |
| Net Income | $-67,044 | $-56,600 | $-53,796 | $-47,092 | $-42,121 |
| EPS Basic Total Ops | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 |
| EPS Basic Continuous Ops | -1.01 | -0.85 | -0.81 | -0.72 | -0.64 |
| EPS Diluted Total Ops | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 |
| EPS Diluted Continuous Ops | -1.01 | -0.85 | -0.81 | -0.72 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 |
| EBITDA(a) | $-73,811 | $-64,672 | $-64,139 | $-58,571 | $-55,673 |